Computerized pharmacy surveillance and alert system for drug-related problems
| Autor: | J. Portabella, O. Urbina, S. Mojal, E. Salas, Santiago Grau, M Marín-Casino, J. Mateu-de-Antonio, M. Riu, O. Ferrández |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
Drug congenital hereditary and neonatal diseases and abnormalities medicine.medical_specialty media_common.quotation_subject Pharmacy Pharmacists 030226 pharmacology & pharmacy Clinical decision support system Medical Order Entry Systems 03 medical and health sciences 0302 clinical medicine Pharmacotherapy medicine Humans Medication Errors Drug Interactions Pharmacology (medical) In patient 030212 general & internal medicine Medical prescription Intensive care medicine Alert system media_common Pharmacology business.industry Electronic medical record nutritional and metabolic diseases Emergency medicine Female Patient Safety business |
| Zdroj: | Journal of Clinical Pharmacy and Therapeutics. 42:201-208 |
| ISSN: | 0269-4727 |
| Popis: | SummaryWhat is known and objective Because of the impact of drug-related problems (DRPs) on morbidity and mortality, there is a need for computerized strategies to increase drug safety. The detection and identification of the causes of potential DRPs can be facilitated by the incorporation of a pharmacy warning system (PWS) in the computerized prescriber order entry (CPOE) and its application in the routine validation of inpatient drug therapy. A limited number of studies have evaluated a clinical decision support system to monitor drug treatment. Most of these applications have utilized a small range of drugs with alerts and/or types of alert. The objective of this study was to describe the implementation of a PWS integrated in the electronic medical record (EMR). Methods The PWS was developed in 2003–2004. Pharmacological information to generate drug alerts was entered on demographic data, drug dosage, laboratory tests related to the prescribed drug and drug combinations (interactions, duplications and necessary combinations). The PWS was applied in the prescription reviews conducted in patients admitted to the hospital in 2012. Results and discussion Information on 83% of the drugs included in the pharmacopeia was introduced into the PWS, allowing detection of 2808 potential DRPs, representing 79·1% of all potential DRPs detected during the study period. Twenty per cent of PWS DRPs were clinically relevant, requiring pharmacist intervention. What is new and conclusion The PWS detected most potential DRPs, thus increasing inpatient safety. The detection ability of the PWS was higher than that reported for other tools described in the literature. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |